Literature DB >> 10086389

Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

C Badorff1, G H Lee, B J Lamphear, M E Martone, K P Campbell, R E Rhoads, K U Knowlton.   

Abstract

Enteroviruses such as Coxsackievirus B3 can cause dilated cardiomyopathy, but the mechanism of this pathology is unknown. Mutations in cytoskeletal proteins such as dystrophin cause hereditary dilated cardiomyopathy, but it is unclear if similar mechanisms underlie acquired forms of heart failure. We demonstrate here that purified Coxsackievirus protease 2A cleaves dystrophin in vitro as predicted by computer analysis. Dystrophin is also cleaved during Coxsackievirus infection of cultured myocytes and in infected mouse hearts, leading to impaired dystrophin function. In vivo, dystrophin and the dystrophin-associated glycoproteins alpha-sarcoglycan and beta-dystroglycan are morphologically disrupted in infected myocytes. We suggest a molecular mechanism through which enteroviral infection contributes to the pathogenesis of acquired forms of dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086389     DOI: 10.1038/6543

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  144 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  Many roads lead to a broken heart: the genetics of dilated cardiomyopathy.

Authors:  J Schönberger; C E Seidman
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

Review 3.  Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis.

Authors:  M W Cunningham
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 4.  Cellular and molecular basis of inflammatory myocardial disease.

Authors:  W H Barry
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

5.  Complexity in simplicity: monogenic disorders and complex cardiomyopathies.

Authors:  J Chen; K R Chien
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

6.  Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury.

Authors:  Richard M Lovering; Patrick G De Deyne
Journal:  Am J Physiol Cell Physiol       Date:  2003-10-01       Impact factor: 4.249

Review 7.  Transformation of myocarditis and inflammatory cardiomyopathy to idiopathic dilated cardiomyopathy: facts and fiction.

Authors:  Hans R Figulla
Journal:  Med Microbiol Immunol       Date:  2003-11-01       Impact factor: 3.402

8.  Exercise-induced left ventricular systolic dysfunction in women heterozygous for dystrophinopathy.

Authors:  Robert M Weiss; Richard E Kerber; Jane K Jones; Carrie M Stephan; Christina J Trout; Paul D Lindower; Kimberly S Staffey; Kevin P Campbell; Katherine D Mathews
Journal:  J Am Soc Echocardiogr       Date:  2010-06-19       Impact factor: 5.251

9.  Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.

Authors:  Roland Zell; René Markgraf; Michaela Schmidtke; Matthias Görlach; Axel Stelzner; Andreas Henke; Holger H Sigusch; Brigitte Glück
Journal:  Med Microbiol Immunol       Date:  2003-09-26       Impact factor: 3.402

Review 10.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.